Opinion | March 24, 2022
Clinical Trials in the New Normal
The accelerated use of technology in clinical trials and the shift towards virtual trials is here to stay
The accelerated use of technology in clinical trials and the shift towards virtual trials is here to stay
Divsa's coverage across Central America bridges Barentz' leading positions in North and South America
The tablets are indicated for the treatment of partial-onset seizures in patients 4 years of age and older
Manipal Hospitals partners with ConnectedLife, leveraging Fitbit wearable technology, for Continuity of Care Post-High-Risk Surgeries built with Google Cloud
If the government feels that the industry is not complying with the uniform code, it will consider making it a statutory code
A growing portfolio of chemicals is part of a larger quality management system that sets new standards in bioprocessing
This is the sixth successful USFDA audit for this facility
RNA, cell & gene therapies, artificial intelligence, CRISPR and oncology-related deals dominate the landscape
As the world celebrates World Glaucoma Week (March 7-13th), Nikkhil K Masurkar, Executive Director, Entod Pharmaceuticals, an authority on eye diseases spoke to Thomas C Thottathil, Editor, indianpharmapost.com, on the seriousness of Glaucoma
Raising awareness about glaucoma is crucial in India where it is the leading cause of irreversible blindness with at least 12 million people affected and almost 1.2 million people blind from the disease
Subscribe To Our Newsletter & Stay Updated
